![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Weinberger D.R. Lipska B.K.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 201-201
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ziprasidone effective in treatment-resistant schizophrenia
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adjunctive Depot Antipsychotic in Treatment-Resistant Schizophrenia
Current Psychopharmacology, Vol. 5, Iss. 1, 2016-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
By Bitter I. Dossenbach M.R.K. Brook S. Feldman P.D. Metcalfe S. Gagiano C.A. Furedi J. Bartko G. Janka Z. Banki C.M. Kovacs G. Breier A. for the Olanzapine HGCK Study Group
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New insights into the treatment of pulmonary fibrosis
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. :